Reversing memory deficits and impairments in spatial learning is a major goal in the field of dementia research. A lack of knowledge about cellular pathways critical to the development of dementia, however, has stood in the way of significant clinical advance. But now, researchers at the Lewis Katz School of Medicine at Temple University (LKSOM) are breaking through that barrier. They show, for the first time in an animal model, that tau pathology – the second-most important lesion in the brain in patients with Alzheimer’s disease – can be reversed by a drug.
“We show that we can intervene after disease is established and pharmacologically rescue mice that have tau-induced memory deficits,” explained senior investigator Domenico Praticò, MD, Scott Richards North Star Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology, and Director of the Alzheimer’s Center at Temple at LKSOM. The study, published online in the journal Molecular Neurobiology, raises new hope for human patients affected by dementia.
The researchers landed on their breakthrough after discovering that inflammatory molecules known as leukotrienes are deregulated in Alzheimer’s disease and related dementias. In experiments in animals, they found that the leukotriene pathway plays an especially important role in the later stages of disease.
“At the onset of dementia, leukotrienes attempt to protect nerve cells, but over the long term, they cause damage,” Dr. Praticò said. “Having discovered this, we wanted to know whether blocking leukotrienes could reverse the damage, whether we could do something to fix memory and learning impairments in mice having already abundant tau pathology.”
To recapitulate the clinical situation of dementia in humans, in which patients are already symptomatic by the time they are diagnosed, Dr. Praticò and colleagues used specially engineered tau transgenic mice, which develop tau pathology – characterized by neurofibrillary tangles, disrupted synapses (the junctions between neurons that allow them to communicate with one another), and declines in memory and learning ability – as they age. When the animals were 12 months old, the equivalent of age 60 in humans, they were treated with zileuton, a drug that inhibits leukotriene formation by blocking the 5-lipoxygenase enzyme.
After 16 weeks of treatment, animals were administered maze tests to assess their working memory and their spatial learning memory. Compared with untreated animals, tau mice that had received zileuton performed significantly better on the tests. Their superior performance suggested a successful reversal of memory deficiency.
To determine why this happened, the researchers first analyzed leukotriene levels. They found that treated tau mice experienced a 90-percent reduction in leukotrienes compared with untreated mice. In addition, levels of phosphorylated and insoluble tau, the form of the protein that is known to directly damage synapses, were 50 percent lower in treated animals. Microscopic examination revealed vast differences in synaptic integrity between the groups of mice. Whereas untreated animals had severe synaptic deterioration, the synapses of treated tau animals were indistinguishable from those of ordinary mice without the disease.
“Inflammation was completely gone from tau mice treated with the drug,” Dr. Praticò said. “The therapy shut down inflammatory processes in the brain, allowing the tau damage to be reversed.”
The study is especially exciting because zileuton is already approved by the Food and Drug Administration for the treatment of asthma. “Leukotrienes are in the lungs and the brain, but we now know that in addition to their functional role in asthma, they also have a functional role in dementia,” Dr. Praticò explained.
“This is an old drug for a new disease,” he added. “The research could soon be translated to the clinic, to human patients with Alzheimer’s disease.”
The Latest on: Dementia
via Google News
The Latest on: Dementia
- Orange County woman with dementia found in ditch but alive after 2-day searchon August 16, 2019 at 9:18 pm
Orange County, N.C. — Search crews on Friday found a missing Orange County woman who suffers from dementia after she walked away from her home two days ago, authorities said. Orange County officials ...
- After days of searching, missing Orange County woman with dementia found aliveon August 16, 2019 at 11:39 am
A 75-year-old woman with dementia was found alive by search crews Friday more than 48 hours after she was reported missing. Crews found Maryanne Rosenman around 11:25 a.m. in a drainage ditch in a ...
- Missing Orange County woman with dementia found 'alive and well'on August 16, 2019 at 11:31 am
Orange County, N.C. — Search crews on Friday found a missing Orange County woman who suffers from dementia after she walked away from her home two day ago, authorities said. Orange County officials ...
- Missing woman with dementia found alive in drainage ditch in Orange County 53 hours after wandering away from homeon August 16, 2019 at 10:05 am
CHAPEL HILL, N.C. (WTVD) -- The 75-year-old Orange County woman with dementia who went missing Wednesday has been found alive and in reasonably good condition. Orange County officials said ...
- Getting a Parent With Dementia the Best Long-Term Care for the Moneyon August 16, 2019 at 4:25 am
Liz Kozlowski and her staff at Brookdale Senior Living’s Westlake Village, outside of Cleveland, knew that resident Ed Petrigac and his wife Yvonne had started an auto parts business. But it wasn’t ...
- Burr Ridge police investigating videos of dementia care patients apparently being mocked, filmed partially naked by employeeson August 16, 2019 at 2:20 am
Burr Ridge police are investigating Snapchat videos taken at a residential facility for people with dementia that appear to show employees mocking and humiliating residents, as well as recording some ...
- A healthy social life fends off dementia, researchers sayon August 16, 2019 at 2:15 am
Staying socially active has always been good advice for staying happy and healthy. Now research shows just how meaningful those conversations and connections can be. People who are more socially ...
- Social activity in your 60s may lower dementia risk by 12%on August 15, 2019 at 8:05 am
Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current ...
- NHS Borders dementia bed cut 'a step in the right direction'on August 15, 2019 at 4:27 am
The number of acute dementia beds in the Scottish Borders is set to be cut by nearly half. The Integrated Joint Board (IJB) - a partnership between NHS Borders and Scottish Borders Council - plans to ...
via Bing News